| Literature DB >> 32059671 |
Mohamad M Traore1, Amy Junnila1, Sekou F Traore1, Seydou Doumbia1, Edita E Revay1, Vasiliy D Kravchenko2, Yosef Schlein3, Kristopher L Arheart4, Petrányi Gergely5, Rui-De Xue6, Axel Hausmann5, Robert Beck5, Alex Prozorov1, Rabiatou A Diarra1, Aboubakr S Kone1, Silas Majambere7, John Bradley8, John Vontas9,10, John C Beier4, Günter C Müller11.
Abstract
BACKGROUND: The aim of this field trial was to evaluate the efficacy of attractive toxic sugar baits (ATSB) in Mali, where sustained malaria transmission occurs despite the use of long-lasting insecticidal nets (LLINs). ATSB bait stations were deployed in seven of 14 similar study villages, where LLINs were already in widespread use. The combined use of ATSB and LLINs was tested to see if it would substantially reduce parasite transmission by Anopheles gambiae sensu lato beyond use of LLINs alone.Entities:
Keywords: ATSB; Anopheles gambiae; Mali; Sugar feeding; Vector control
Mesh:
Substances:
Year: 2020 PMID: 32059671 PMCID: PMC7023716 DOI: 10.1186/s12936-020-3132-0
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
Map coordinates, population, and distance to the Niger river of control and experimental villages
| Control villages | Latitude, longitude | Pop. | Dist. (km) | Treated villages | Latitude, longitude | Pop. | Dist. (km) |
|---|---|---|---|---|---|---|---|
| Balandougou | 11.985750, − 8.51395 | < 500 | > 5 | Krekrelo | 11.98836, − 8.551460 | < 500 | > 5 |
| Madina | 12.05229, − 8.373600 | < 500 | < 5 | Sirakele | 11.95466, − 8.446560 | < 500 | > 5 |
| Korea | 12.04576, − 8.399230 | < 500 | > 5 | Trekrou | 12.068577, − 8.314414 | > 500 | < 5 |
| Balala | 11.96599, − 8.468310 | > 500 | > 5 | Farabale | 12.03865, − 8.424590 | < 500 | > 5 |
| Cissebougou | 12.09628, − 8.372850 | > 500 | > 5 | Kignele | 11.96737, − 8.397900 | > 500 | < 5 |
| Nianguanabougou | 12.15466, − 8.308260 | > 500 | < 5 | Tiko | 12.13444, − 8.396860 | > 500 | > 5 |
| Trekrouba | 12.073598, − 8.258717 | > 500 | < 5 | Sambadani | 12.14454, − 8.316880 | > 500 | < 5 |
Pop population, Dist distance to river
Fig. 1A Comparison of the mean number of female Anopheles gambiae s.l. (± SE) collected per trap per village from ATSB treated and control villages. The pre-treatment monitoring period was from April until ATSB treatment on May 31st Control and experimental sites were monitored from June to December. a catch of CDC traps; b catch of Malaise traps; c PSCs. B Comparison of the mean number of male Anopheles gambiae s.l. (± SE) collected per trap per village from ATSB treated and from control villages. The pre-treatment monitoring period was from April until ATSB treatment in the 31 of May; All sites were monitored from June to December. a Catch of CDC traps; b Catch of Malaise traps; c PSC catches
Baseline mean (± SE) of male and female An. gambiae that had natural sugar in the gut before presentation of ASB (Day 1)
| Month | Day 1—Anthrone positive (Natural sugar-fed) | ||||
|---|---|---|---|---|---|
| Female | Male | ||||
| Meana ± SE | % of catch | Month | Meana ± SE | % of catch | |
| Apr N = 85 | 2.57 ± 1.08 | 21.10 | Apr N = 2 | 0.28 ± 0.18 | 0.00 |
| May N = 65 | 1.17 ± 0.77 | 18.90 | May N = 1 | 0.14 ± 0.14 | 0.00 |
| Jun N = 75 | 3.42 ± 1.19 | 32.00 | Jun N = 2 | 0.28 ± 0.28 | 0.00 |
| Jul N = 350 | 17.71 ± 3.02 | 39.70 | Jul N = 140 | 20.00 ± 2.43 | 44.00 |
| Aug N = 350 | 22.43 ± 1.70 | 44.90 | Aug N = 145 | 20.86 ± 1.22 | 41.80 |
| Sept N = 350 | 20.57 ± 2.26 | 41.10 | Sept N = 160 | 22.57 ± 1.46 | 45.10 |
| Oct N = 350 | 18.86 ± 1.92 | 37.70 | Oct N = 125 | 17.86 ± 1.71 | 41.80 |
| Nov N = 300 | 13.43 ± 1.64 | 31.30 | Nov N = 15 | 2.28 ± 1.07 | 28.10 |
| Dec N = 250 | 8.14 ± 2.72 | 22.70 | Dec N = 1 | 0.14 ± 0.14 | 0.00 |
N = Total pooled sample size from all villages
aMean positive per village
Comparison of the means of males and females feeding on natural sugar versus those feeding on ASB per village (± SE with 95% CI of the difference between means)
| Month | Day 2—Anthrone positive (Natural sugar-fed) vs. ASB positive | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Female anth | Female ASB | Male anth | Male ASB | ||||||||||
| Meana ± SE | Mean ± SE | Diff | 95% CIb | P value | Month | Meana ± SE | Mean ± SE | Diff | 95% CIb | P value | |||
| Apr N = 88 | 0.71 ± 0.29 | 5.86 ± 1.65 | 5.15 | 7.42 | 2.88 | < 0.0001 | Apr N = 2 | 0.00 ± 0.00 | 0.14 ± 0.14 | 0.14 | 1.32 | 0.00 | 0.5010 |
| May N = 60 | 0.43 ± 0.20 | 3.71 ± 1.17 | 3.28 | 5.55 | 1.01 | 0.0010 | May N = 1 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 | 1.18 | 0.00 | 0.9720 |
| Jun N = 80 | 0.57 ± 0.30 | 4.29 ± 1.87 | 3.72 | 5.99 | 1.45 | 0.0010 | Jun N = 3 | 0.14 ± 0.14 | 0.14 ± 0.14 | 0.00 | 1.18 | 0.00 | 0.9940 |
| Jul N = 320 | 7.57 ± 1.54 | 16.14 ± 2.23 | 8.57 | 10.84 | 6.30 | 0.0050 | Jul N = 310 | 5.86 ± 0.63 | 15.29 ± 1.19 | 9.43 | 10.61 | 8.25 | < 0.0001 |
| Aug N = 350 | 10.86 ± 1.79 | 13.86 ± 1.75 | 3.00 | 5.27 | 0.73 | 0.0034 | Aug N = 350 | 8.00 ± 1.21 | 15.43 ± 1.53 | 7.43 | 8.61 | 6.25 | < 0.0001 |
| Sept N = 350 | 6.71 ± 1.04 | 17.57 ± 2.37 | 10.86 | 13.13 | 8.59 | < 0.0001 | Sept N = 350 | 5.71 ± 0.61 | 15.71 ± 1.34 | 10.00 | 11.18 | 8.82 | < 0.0001 |
| Oct N = 350 | 6.71 ± 1.13 | 15.14 ± 1.99 | 8.43 | 10.70 | 6.16 | 0.0030 | Oct N = 300 | 6.00 ± 0.93 | 13.86 ± 1.03 | 7.86 | 9.04 | 6.68 | < 0.0001 |
| Nov N = 300 | 2.71 ± 0.68 | 16.00 ± 2.17 | 13.29 | 15.56 | 11.02 | < 0.0001 | Nov N = 60 | 0.29 ± 0.18 | 3.29 ± 1.04 | 3.00 | 4.18 | 1.82 | 0.0020 |
| Dec N = 250 | 1.71 ± 0.52 | 11.57 ± 1.38 | 9.86 | 12.13 | 7.59 | < 0.0001 | Dec N = 5 | 0.14 ± 0.14 | 0.29 ± 0.29 | 0.15 | 1.33 | 0.00 | 0.9980 |
Catches of the first night post-presentation of ASB (Day 2)
N = Total pooled sample size from all villages
Diff difference between means
aMean positive per village
bColumn 1 = upper limit, column 2 = lower limit
A Percentage reduction of female Anopheles gambiae s.l. per trap per village observed comparing ATSB treated sites and control sites; 95% CIs of the mean difference are shown in Fig. 1A. B Reduction of An. gambiae s.l. male catches per trap in ATSB treated sites and control sites with 95% CIs of the mean difference is shown in Fig. 1A
| CDC ATSB sites vs CDC control sites | Malaise ATSB sites vs Malaise control sites | PSC ATSB sites vs PSC control sites | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Month | Diff. | 95% CI UL | 95% CI LL | % reduct | P value | Diff. | 95% CI UL | 95% CI LL | % reduct | P value | Diff. | 95% CI UL | 95% CI LL | % reduct | P value |
| Aa | |||||||||||||||
| Apr | 0.06 | 0.41 | 0.00 | N/A | 0.8860 | 0.05 | 1.75 | 0.00 | N/A | 0.8300 | 2.30 | 6.35 | 0.00 | N/A | 0.1830 |
| May | 0.11 | 0.58 | 0.00 | N/A | 0.9070 | 0.33 | 1.47 | 0.00 | N/A | 0.4170 | 1.63 | 6.02 | 0.00 | N/A | 0.2620 |
| Jun | 0.72 | 1.19 | 0.00 | 94.74 | 0.0140 | 0.49 | 1.29 | 0.00 | 83.05 | 0.0184 | 1.31 | 5.96 | 0.00 | 71.20 | 0.0780 |
| Jul | 7.54 | 17.01 | 0.00 | 85.39 | 0.0010 | 6.95 | 14.75 | 0.00 | 75.63 | 0.0030 | 4.85 | 9.50 | 0.20 | 64.15 | 0.0180 |
| Aug | 24.95 | 34.42 | 15.48 | 60.47 | 0.0080 | 9.30 | 17.10 | 1.50 | 35.89 | 0.0171 | 4.44 | 9.09 | 0.00 | 38.18 | 0.0220 |
| Sept | 30.85 | 40.34 | 21.38 | 57.38 | 0.0090 | 17.38 | 25.18 | 9.58 | 44.33 | 0.0460 | 9.47 | 14.12 | 4.82 | 48.66 | 0.0400 |
| Oct | 28.36 | 37.83 | 18.89 | 67.75 | 0.0010 | 12.88 | 20.68 | 5.08 | 61.13 | 0.0060 | 5.95 | 10.60 | 1.30 | 65.67 | 0.0100 |
| Nov | 11.48 | 20.95 | 2.01 | 82.18 | 0.0010 | 11.20 | 19.00 | 3.40 | 75.22 | 0.0010 | 4.07 | 8.72 | 0.00 | 79.18 | 0.0030 |
| Dec | 4.7 | 14.17 | 0.00 | 91.09 | 0.0010 | 5.79 | 13.59 | 0.00 | 84.03 | 0.0010 | 2.53 | 7.18 | 0.00 | 87.24 | 0.0060 |
| Bb | |||||||||||||||
| Apr | 0.29 | 2.54 | − 3.12 | N/A | 0.9200 | 0.00 | 3.20 | 0.00 | N/A | 0.8300 | 0.10 | 1.29 | 0.00 | N/A | 0.1830 |
| May | 0.21 | 2.62 | − 3.04 | N/A | 0.5580 | 0.83 | 2.37 | 0.00 | N/A | 0.4170 | 0.10 | 1.09 | 0.00 | N/A | 0.2620 |
| Jun | 0.63 | 3.46 | − 2.20 | 94.03 | 0.0076 | 0.44 | 3.64 | 0.00 | 100.00 | 0.1840 | 0.00 | 1.19 | 0.00 | 0.00 | 0.0480 |
| Jul | 0.01 | 2.84 | − 2.82 | 0.83 | 0.0010 | 2.40 | 5.60 | 0.00 | 48.98 | 0.0030 | 1.70 | 2.89 | 0.51 | 56.67 | 0.0180 |
| Aug | 4.19 | 7.02 | 1.36 | 30.56 | 0.0110 | 7.08 | 10.28 | 3.88 | 41.94 | 0.1710 | 3.50 | 4.69 | 2.31 | 50.72 | 0.0220 |
| Sept | 2.81 | 5.64 | − 0.02 | 28.07 | 0.0190 | 4.50 | 7.70 | 1.30 | 36.98 | 0.0760 | 4.10 | 5.29 | 2.91 | 45.56 | 0.0400 |
| Oct | 2.48 | 5.31 | − 0.35 | 52.99 | 0.0080 | 4.02 | 7.22 | 0.82 | 59.82 | 0.0060 | 2.10 | 3.29 | 0.91 | 67.74 | 0.0100 |
| Nov | 0.67 | 3.50 | − 2.16 | 72.83 | 0.0015 | 1.18 | 4.39 | 0.00 | 80.54 | 0.0001 | 1.30 | 2.49 | 0.11 | 86.67 | 0.0030 |
| Dec | 5.14 | 7.97 | 2.30 | 99.73 | 0.0039 | 0.46 | 3.66 | 0.00 | 92.00 | 0.0010 | 0.30 | 1.49 | 0.00 | 100.00 | 0.0060 |
Horizontal line—ATSB treatment
N/A not applicable, pre-treatment monitoring period, Diff. difference between means, UL upper limit, LL lower limit
aP values of the comparison between mean numbers of females caught per trap per village in Fig. 1A are also shown
bP values of the comparison between mean numbers of males caught per trap in Fig. 1A are also shown
Reduction of indoor and outdoor landing/biting of female An. gambiae s.l. per volunteer per night, from control sites compared to ATSB treated sites
| Month | Indoor | Outdoor | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Diff. | 95% CI UL | 95% CI LL | % reduct | P value | Diff. | 95% CI UL | 95% CI LL | % reduct | P value | |
| Apr | 0.50 | 8.39 | − 9.39 | N/A | N/A | 0.43 | 10.63 | − 9.77 | N/A | N/A |
| May | 0.43 | 8.46 | − 9.32 | N/A | N/A | − 0.07 | 10.13 | − 10.27 | N/A | N/A |
| Jun | 3.64 | 12.54 | − 5.25 | 48.11 | 0.014 | 6.20 | 16.40 | 4.00 | 80.67 | 0.006 |
| Jul | 8.07 | 16.96 | 0.82 | 37.08 | 0.046 | 11.21 | 21.41 | 1.01 | 43.41 | 0.043 |
| Aug | 7.29 | 16.18 | 1.61 | 25.32 | 0.042 | 6.22 | 16.42 | 3.98 | 20.85 | 0.075 |
| Sept | 2.79 | 11.68 | 0.11 | 19.75 | 0.046 | 6.19 | 16.38 | 4.01 | 26.34 | 0.064 |
| Oct | 13.36 | 22.25 | 4.46 | 42.34 | 0.018 | 15.36 | 25.56 | 5.16 | 55.30 | 0.011 |
| Nov | 7.93 | 16.82 | 0.96 | 65.29 | 0.033 | 5.32 | 15.52 | 0.88 | 61.94 | 0.034 |
| Dec | 4.36 | 13.25 | 0.54 | 68.68 | 0.025 | 1.82 | 12.02 | 0.38 | 74.42 | 0.043 |
(Differences are significant if P < 0.05)
Horizontal line—ATSB treatment
N/A not applicable, pre-treatment monitoring period, Diff. difference in means
Fig. 3The mean number per village of Anopheles gambiae s.l. females that passed ≥ 3 egg laying cycles in control villages and after treatment with ATSB. *Indicates absence of mosquitoes
Comparison of the number of female An. gambiae s.l. that passed ≥ 3 egg laying cycles from control sites and ATSB treated sites after the pre-treatment monitoring period
| ATSB (N) | ATSB sites | Control sites | ||||||
|---|---|---|---|---|---|---|---|---|
| Mean ± SE | Control (N) | Mean ± SE | Diff. | 95% CI UL | 95% CI LL | % reduct | P value | |
| Apr N = 160 | 3.50 ± 0.60 | Apr N = 160 | 3.50 ± 0.90 | 0.00 | 7.21 | − 7.21 | N/A | 0.6960 |
| May N = 158 | 5.20 ± 0.60 | May N = 158 | 5.60 ± 1.10 | 0.40 | 7.61 | − 6.81 | N/A | 0.4000 |
| Jun N = 220 | 0.40 ± 0.21 | Jun N = 220 | 8.20 ± 1.18 | 7.80 | 15.01 | 0.59 | 95.12 | 0.1480 |
| Jul N = 600 | 1.00 ± 0.27 | Jul N = 600 | 11.80 ± 2.13 | 10.80 | 18.01 | 3.59 | 91.53 | 0.0110 |
| Aug N = 600 | 6.60 ± 1.80 | Aug N = 600 | 43.00 ± 11.78 | 36.40 | 43.61 | 29.19 | 84.65 | < 0.0001 |
| Sept N = 600 | 5.40 ± 1.66 | Sept N = 600 | 49.20 ± 12.70 | 43.80 | 51.01 | 36.59 | 89.02 | < 0.0001 |
| Oct N = 600 | 1.60 ± 0.21 | Oct N = 600 | 56.00 ± 8.69 | 54.40 | 61.61 | 47.19 | 97.14 | < 0.0001 |
| Nov N = 370 | 0.40 ± 0.21 | Nov N = 370 | 30.20 ± 2.91 | 29.80 | 37.01 | 22.59 | 98.68 | < 0.0001 |
| Dec N = 135 | 0.00 ± 0.00 | Dec N = 135 | 14.00 ± 3.48 | 14.00 | 21.21 | 6.79 | 100.00 | 0.9630 |
N/A not applicable, Diff. difference between means
N = Total number dissected from CDC, malaise and PSC catches
Horizontal line—ATSB treatment
Monthly means of biting pressure, sporozoite infection in females (determined by ELISA), and the frequency of entomological inoculation (EIR)
| A | Indoor treated sites | Indoor control sites | Monthly EIR reduction (%) | P-value | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Month | Monthly Ave BP | Ave testedb | Ave # infected | Infection rate (IR) | Monthly EIR | Monthly Ave BP | Ave testedb | Ave # infected | Infection rate (IR) | Monthly EIR | ||
| Apr | 162.86 | 10.86 | 0.00 | 0.0000 | 0.00 | 147.86 | 9.86 | 0.00 | 0.0000 | 0.00 | N/A | N/A |
| May | 124.29 | 8.29 | 0.00 | 0.0000 | 0.00 | 111.43 | 7.43 | 0.00 | 0.0000 | 0.00 | N/A | N/A |
| Jun | 117.86 | 7.86 | 0.00 | 0.0000 | 0.00 | 227.14 | 14.86 | 0.29 | 0.0200 | 4.37 | 100.00 | 0.3085 |
| Jul | 720.00 | 48.00 | 0.29 | 0.0100 | 4.29 | 962.14 | 64.14 | 1.29 | 0.0200 | 19.29 | 77.76 | 0.0880 |
| Aug | 1527.86 | 101.57 | 0.29 | 0.0030 | 4.30 | 1746.43 | 116.86 | 3.00 | 0.0300 | 44.83 | 90.41 | < 0.001 |
| Sept | 1714.29 | 114.29 | 0.71 | 0.0100 | 10.71 | 1797.86 | 119.86 | 4.71 | 0.0400 | 70.71 | 84.85 | < 0.001 |
| Oct | 548.57 | 36.57 | 0.43 | 0.0100 | 6.43 | 949.29 | 63.29 | 3.14 | 0.0500 | 47.14 | 86.36 | < 0.001 |
| Nov | 126.43 | 8.43 | 0.00 | 0.0000 | 0.00 | 364.29 | 24.29 | 0.29 | 0.0100 | 4.29 | 100.00 | 0.9999 |
| Dec | 47.14 | 3.14 | 0.00 | 0.0000 | 0.00 | 177.86 | 11.86 | 0.00 | 0.0000 | 0.00 | N/A | N/A |
Measurements were made using human landing catches. A) Indoor B) Outdoor
N/A Not applicable, no reduction
aBP = (#bites/person/night)
bAverage out of a maximum sample size of 150/village
IR = # Infected/# tested
Horizontal line = ATSB treatment
Fig. 4Mean number per village and month (± SE) of female Anopheles gambiae s.l., collected from all trapping methods and found infected with sporozoites in control villages compared to treated villages
Monthly comparison of the mean number of sporozoite infected female An. gambiae s.l. at the ATSB treated sites versus the control sites
| Month | ATSB sites | Month | Control sites | Diff. | 95% CI UL | 95% CI LL | % reduct | P value |
|---|---|---|---|---|---|---|---|---|
| ATSB (N) | Mean ± SE | Control (N) | Mean ± SE | |||||
| Apr N = 120 | 0.00 ± 0.00 | Apr N = 120 | 0.00 ± 0.00 | 0.00 | N/A | N/A | N/A | N/A |
| May N = 120 | 0.00 ± 0.00 | May N = 120 | 0.00 ± 0.00 | 0.00 | N/A | N/A | N/A | N/A |
| Jun N = 220 | 0.00 ± 0.00 | Jun N = 220 | 0.14 ± 0.49 | 0.54 | 3.35 | − 2.28 | 100.00 | 0.9996 |
| Jul N = 600 | 0.00 ± 0.25 | Jul N = 600 | 1.14 ± 1.16 | 2.54 | 5.35 | − 0.28 | 100.00 | 0.1035 |
| Aug N = 600 | 0.43 ± 0.11 | Aug N = 600 | 2.86 ± 0.85 | 4.86 | 7.67 | 2.05 | 84.97 | < 0.0001 |
| Sept N = 600 | 0.43 ± 0.24 | Sept N = 600 | 3.86 ± 1.28 | 6.11 | 8.92 | 3.30 | 88.86 | < 0.0001 |
| Oct N = 600 | 0.14 ± 0.04 | Oct N = 600 | 3.29 ± 1.57 | 5.29 | 8.10 | 2.48 | 95.74 | < 0.0001 |
| Nov N = 360 | 0.00 ± 0.00 | Nov N = 360 | 0.14 ± 1.24 | 2.54 | 5.35 | − 0.28 | 100.00 | 0.1035 |
| Dec N = 120 | 0.00 ± 0.00 | Dec N = 120 | 0.00 ± 0.71 | 1.00 | 3.81 | − 1.81 | N/A | 0.9646 |
N/A Not applicable, no reduction, Diff. difference between treatment and control means
Horizontal line—ATSB treatment
N = Total number tested from CDC, malaise, PSC and HLC catches
Fig. 2Landing/biting of Anopheles gambiae females in HLC observations after placement of ATSB bait stations. Data collected indoor and outdoor from ATSB treated villages, and from control villages, were grouped and the mean number of landing/biting per volunteer per night was calculated for each month. a Indoor, b outdoor